Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2025 inter alia to consider and approve Proposed Agro-Pharma Research Laboratory & to consider fund-raising by QIP

A.G.M. & Inter alia, to consider and approve:- 1. To approve appointment of Cost Auditor of the Company for financial year 2025-2026. 2. To consider, approve, and recommend the appointment of the Secretarial Auditor of the Company, Subject to Shareholders' approval at ensuing Annual General Meeting of the Company 3. To consider and approve for disposal of the Company's undertaking and/or investment in subsidiary under Section 180(1)(a) of the Companies Act, 2013, subject to the approval of the shareholders at the ensuing Annual General Meeting. 4. To approve Board's Report along with all its annexure ,Secretarial Audit Report, Corporate Governance Report and for the Financial Year 2024-25; 5. To fix the date, time, and venue of the 37th Annual General Meeting of the Company. 6. To fix the date of Book Closure for the purpose of the 37th Annual General Meeting of the Company. 7. To fix the cutoff date for eligibility to participate in E-voting in the 37th Annual General Meeting of the Company. and other matters as per notice.

Baroda Extrusion Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2025 inter alia to consider and approve 1. Allotment of Equity Shares in accordance with rules and regulations of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and to consider other matters consequential thereto and with approval of the shareholders in the members meeting held on 02-05-2025 and In principle Approval of Shareholders as on 14-08-2025. 2. Any other matter with the permission of Chair.

Kapil Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2025 inter alia to consider and approve the Proposal on Change of Name and Object Clause Increase in Authorized Capital and transactions as mentioned in attached Intimation.

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2025 inter alia to consider and approve 1. To fix day date and Time for the ensuing Annual General Meeting for the financial year 2024-25. 2. To Consider and approve Notice of AGM Boards Report and Secretarial Audit Report. 3. To fix date for book closure. 4. To appoint intermediate agencies like CDSL/NSDL for E-Voting. 5. To appoint M/S. Lakshmmi Subramanian & Associates as scrutinizer for e-voting to be conducted in the ensuing annual general meeting.